Medlive Technology Co., Ltd. logo

Medlive Technology Co., Ltd.

2192.HK

HKSEHealthcareMedical - Healthcare Information Services

Latest quote

HK$7.55

−HK$0.18 · -2.33%

Aug 24, 4:08 PM HKT

2192.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Medlive Technology Co., Ltd., along with its affiliated entities, manages a digital platform tailored for medical professionals, serving both the Chinese mainland and international markets. Through its comprehensive platform, the company delivers a precision marketing and corporate solution encompassing a wide array of services. These include project oversight, clinical supervision, handling of clinical data, biostatistical analysis, drafting of study protocols, medical supervision, patient enrollment, and system support. Furthermore, it offers digital market intelligence, electronic data collection, real-world evidence generation, and the development of application software. Medlive also provides a medical knowledge solution focused on continuing medical education and tools for clinical decision-making, which involves licensing specialized software to physicians and other registered users, including various healthcare practitioners and pharmaceutical corporations. An intelligent patient management solution is another core offering, delivering chronic disease management services that cover online consultations, prescription fulfillment, and patient care facilitated by an Internet hospital. Additionally, it provides condition-specific patient education, involving the creation of content, development of specialized software, and associated support services. Originally established in 1996 as Kingyee Co., Limited, the enterprise adopted the name Medlive Technology Co., Ltd. in 2021. Its corporate headquarters are located in Beijing, China.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
CN
CEO
Liping Tian
Listed since
Jul 15, 2021
Employees
724

Market position

52-week range

Current HK$7.55

Open
HK$7.55
Previous close
HK$7.73
Volume
876K
0.6× average
Average volume
1.45M
Average daily volume
Market cap
5.59B HKD
Beta
0.44
Market reference 1
50-day average
HK$7.4299
+1.62% above average
200-day average
HK$8.9209
-15.37% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.86B CNY
P/E (TTM)
14.39×
P/B (TTM)
0.98×
P/S (TTM)
7.46×
EV / EBITDA
22.06×
Earnings yield
5.21%
Free cash flow yield
1.90%
Dividend yield
3.85%

Profitability & efficiency

Gross margin
60.02%
Operating margin
14.31%
Net margin
52.07%
Return on equity
6.87%
Return on assets
6.48%
Return on invested capital
1.79%

Financial health

Debt / equity
Current ratio
19.09×
Altman Z-score
14.12
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends77%51%25%-2%Gross margin, FY2021: 70.57%Gross margin, FY2022: 67.74%Gross margin, FY2023: 61.00%Gross margin, FY2024: 58.59%Gross margin, FY2025: 60.02%Operating margin, FY2021: 16.78%Operating margin, FY2022: 4.83%Operating margin, FY2023: 4.81%Operating margin, FY2024: 9.61%Operating margin, FY2025: 14.31%Net margin, FY2021: 14.28%Net margin, FY2022: 37.36%Net margin, FY2023: 58.81%Net margin, FY2024: 56.43%Net margin, FY2025: 52.07%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 70.57%. Gross margin FY2022 67.74%. Gross margin FY2023 61.00%. Gross margin FY2024 58.59%. Gross margin FY2025 60.02%. Operating margin FY2021 16.78%. Operating margin FY2022 4.83%. Operating margin FY2023 4.81%. Operating margin FY2024 9.61%. Operating margin FY2025 14.31%. Net margin FY2021 14.28%. Net margin FY2022 37.36%. Net margin FY2023 58.81%. Net margin FY2024 56.43%. Net margin FY2025 52.07%.

Income trends

Revenue

642.16M CNY+14.99%

Operating income

91.87M CNY+71.25%

Net income

334.34M CNY+6.09%
Income trends across reported periods704.85M CNY454.06M CNY203.26M CNY−47.53M CNYRevenue, FY2021: 284.44M CNYRevenue, FY2022: 314.05M CNYRevenue, FY2023: 412M CNYRevenue, FY2024: 558.46M CNYRevenue, FY2025: 642.16M CNYOperating income, FY2021: 47.74M CNYOperating income, FY2022: 15.17M CNYOperating income, FY2023: 19.82M CNYOperating income, FY2024: 53.65M CNYOperating income, FY2025: 91.87M CNYNet income, FY2021: 40.62M CNYNet income, FY2022: 117.32M CNYNet income, FY2023: 242.3M CNYNet income, FY2024: 315.15M CNYNet income, FY2025: 334.34M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 284.44M CNY. Revenue FY2022 314.05M CNY. Revenue FY2023 412M CNY. Revenue FY2024 558.46M CNY. Revenue FY2025 642.16M CNY. Operating income FY2021 47.74M CNY. Operating income FY2022 15.17M CNY. Operating income FY2023 19.82M CNY. Operating income FY2024 53.65M CNY. Operating income FY2025 91.87M CNY. Net income FY2021 40.62M CNY. Net income FY2022 117.32M CNY. Net income FY2023 242.3M CNY. Net income FY2024 315.15M CNY. Net income FY2025 334.34M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue642.16M CNY558.46M CNY412M CNY314.05M CNY284.44M CNY
Cost of goods sold256.71M CNY231.23M CNY160.67M CNY101.31M CNY83.71M CNY
Gross profit385.44M CNY327.22M CNY251.34M CNY212.74M CNY200.73M CNY
Research and development76.53M CNY64.58M CNY59.95M CNY46.23M CNY25.33M CNY
Selling, general, and administrative217.04M CNY208.99M CNY177.26M CNY151.34M CNY127.67M CNY
Operating expenses293.57M CNY273.58M CNY231.51M CNY197.57M CNY153M CNY
Interest income177.59M CNY204.72M CNY183.88M CNY66.24M CNY7.71M CNY
Interest expense552K CNY786K CNY361K CNY531K CNY535K CNY
Depreciation and amortization7.63M CNY3.91M CNY9.37M CNY8.99M CNY6.15M CNY
Operating income91.87M CNY53.65M CNY19.82M CNY15.17M CNY47.74M CNY
Net income334.34M CNY315.15M CNY242.3M CNY117.32M CNY40.62M CNY

Company facts updated Aug 25, 2026.

Earnings

EPS beat rate
50%
3 beats, 3 misses, 0 met estimates
Average EPS surprise
-15.27%
6 comparable reports
Latest EPS result
0.27

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.310.220.130.04Q3 '22MissQ1 '23BeatQ3 '23BeatQ1 '24BeatQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 25, 2022: actual 0.043, estimate 0.07, surprise -39.19%, Miss. Q1 2023, reported Mar 24, 2023: actual 0.14, estimate 0.113, surprise +23.85%, Beat. Q3 2023, reported Aug 29, 2023: actual 0.145, estimate 0.097, surprise +48.88%, Beat. Q1 2024, reported Mar 25, 2024: actual 0.217, estimate 0.187, surprise +16.10%, Beat. Q3 2024, reported Aug 27, 2024: actual 0.213, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 24, 2025: actual 0.244, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 0.23, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 0.267, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates585.4M443.36M301.32M159.27MQ1 '23MissQ3 '23BeatQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26MissQ3 '26Estimate
Q1 2023, reported Mar 24, 2023: actual 207.4M HKD, estimate 455.92M HKD, surprise -54.51%, Miss. Q3 2023, reported Aug 29, 2023: actual 187.63M HKD, estimate 187.38M HKD, surprise +0.13%, Beat. Q1 2024, reported Mar 25, 2024: actual 263.97M HKD, estimate 555.92M HKD, surprise -52.52%, Miss. Q3 2024, reported Aug 27, 2024: actual 261.43M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 24, 2025: actual 335.11M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 341.4M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 367.25M HKD, estimate 367.26M HKD, surprise -0.00%, Miss. Q3 2026, reported Aug 28, 2026: actual —, estimate 422.93M HKD, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.2757

2025 complete year+44.2% since 2023

2026 partial: HK$0.1629

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend May 19, 2026

HK$0.1629

Semi-Annual

Record May 21, 2026 · Payment Jun 12, 2026

Dividend

Ex-dividend Sep 5, 2025

HK$0.1277

Semi-Annual

Record Sep 8, 2025 · Payment Sep 25, 2025

Dividend

Ex-dividend May 12, 2025

HK$0.148

Semi-Annual

Record May 14, 2025 · Payment Jun 6, 2025

Dividend

Ex-dividend Oct 22, 2024

HK$0.132

Semi-Annual

Record Oct 24, 2024 · Payment Nov 18, 2024

Dividend

Ex-dividend May 28, 2024

HK$0.1375

Semi-Annual

Record May 29, 2024 · Payment Jun 24, 2024

Dividend

Ex-dividend Nov 7, 2023

HK$0.1165

Semi-Annual

Record Nov 8, 2023 · Payment Dec 4, 2023

2192.HK peers

ETFs holding 2192.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2192.HK

research.disclaimer